WCM Investment Management
WX

WCM Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

WCM Investment Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-148,489
Closed -$6.42M – 115
2015
Q3 		$6.42M Buy
148,489
+14,285
+11% +$603K 0.16% 73
2015
Q2 		$5.67M Buy
134,204
+50,700
+61% +$2.14M 0.13% 89
2015
Q1 		$3.24M Buy
+83,504
New +$3.22M 0.07% 105

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

WCM Investment Management's WX Position: Q4 2015 in Review

WCM Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 148,489 shares — an estimated $6.42M sold.

WCM Investment Management first reported a position in WX in Q1 2015 and held it in 3 quarters. The position peaked at $6.42M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • WCM Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • WCM Investment Management sold 148,489 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $6.42M.
  • WCM Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2015 and held it in 3 quarters.
  • WCM Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $6.42M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on WCM Investment Management's 13F filing for Q4 2015, filed 10 Feb 2016.